Abstract
BackgroundTo control the overpopulation and unintended pregnancies, vaginal contraceptives have gained recent surge of interest because of its topical application with possible avoidance of systemic effects. However non-specific cytotoxicity associated with detergent-based synthetic vaginal contraceptive agents limits their use and generates considerable interest in the development of vaginal contraceptives of biological origin for controlling reproduction and ultimately growing population. In this study, we have cloned, over-expressed an Escherichia coli gene encoding a sperm immobilizing factor (SIF) that inhibits sperm motility for the development of vaginal contraceptive from a biological source i.e. E. coli. The contraceptive efficacy of the Escherichia coli recombinant sperm immobilizing factor (r-SIF) was also determined.MethodsGenomic DNA library of an E. coli strain isolated from semen sample of an infertile male was constructed for the identification and cloning of E. coli SIF coding gene. This gene was sub-cloned in pBADmycHisB for over-expression and the r-SIF was purified using Ni-NTA affinity chromatography. Effect of r-SIF on mouse sperm motility, viability and on morphology was evaluated. Binding of r-SIF to mouse sperm was demonstrated by fluorescent labeling. Contraceptive efficacy of r-SIF was checked in murine model.ResultsGenomic library resulted in five hundred transformants; five clones were found positive for sperm immobilizing activity. The protein product of the insert DNA sequence in one of the transformants showed maximum sperm immobilizing activity. Sequence analysis of ORFs in the insert revealed homology to recX on both nucleotide and protein level. 40 μg of the purified r-SIF showed immediate spermicidal activity in vitro for mouse sperm. Scanning electron micrograph of the r-SIF treated sperm showed intense morphological damage to sperm. FITC labeled r-SIF showed highest fluorescence at the head region of the sperm. 5 μg of purified r-SIF exhibited a complete contraceptive effect in mouse model.Conclusionr-SIF could be seen as potential target to be developed as potent and safe vaginal contraceptive in future.
Highlights
To control the overpopulation and unintended pregnancies, vaginal contraceptives have gained recent surge of interest because of its topical application with possible avoidance of systemic effects
Screening for sperm immobilizing factor (SIF) positive clones resulted in five positive transformants which exhibited sperm immobilizing activity while E. coli DH5α harboring plasmid pSMART did not show sperm immobilizing activity
Binding of FITC labeled recombinant sperm immobilizing factor (r-SIF) to mouse sperm r-SIF was conjugated with Fluorescein isothiocyanate (FITC) using FITC protein labeling kit (Bangalore Genei, India) according to manufacturer’s instructions
Summary
To control the overpopulation and unintended pregnancies, vaginal contraceptives have gained recent surge of interest because of its topical application with possible avoidance of systemic effects. Cultural biases and improper use or breakage during intercourse are some other compromising issues related to the efficacy of condoms [6] Other approaches such as emergency contraception are not popular due to high cost and requirement of clinical supervision to certain extent [7]. The whole playscript reflects that only 5% of unwanted births are due to contraceptive failure and remaining 95% above burden is from women who do not use any contraception, experience gaps in the use of contraception, or use contraception incorrectly or inconsistently [8] To turn this enormity corner, scientific predilections should be inclined on new targets that might be exploited for the development of safe, effective and inexpensive contraceptive agents
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
